3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
265
INDUSTRY
130
NETWORK
19
NIH
15
OTHER_GOV
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Lymphoma, Large B-Cell, Diffuse
1
Colorectal Neoplasms
1
Interventions
Dexamethasone
4
Cyclophosphamide
3
pomalidomide
2
pegylated granulocyte colony-stimulating factor
2
pegfilgrastim
2
carfilzomib
2
Etoposide
2
Cytarabine
2
Bortezomib
2
fosaprepitant
1
fludarabine
1
daratumumab
1
Zoledronic Acid
1
Vaccination
1
Tropisetron
1
Thiotepa
1
Renal Replacement Therapy
1
Prednisone
1
Pneumococcal Vaccines
1
Olanzapine
1
Melphalan
1
Lenalidomide
1
Granulocyte Colony-Stimulating Factor
1
Cyclosporine
1
Azacitidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Multiple Myeloma
×
Lenalidomide
×
Clear all
NCT04065789
2022-01-27
KyDaR
Tel-Aviv Sourasky Medical Center
Phase 2
Completed
41 enrolled